A Mechanism-Based Pharmacokinetic Model for the Cytochrome P450 Drug–Drug Interaction between Cyclophosphamide and ThioTEPA and the Autoinduction of Cyclophosphamide
Assessment of Actual Significance Levels for Covariate Effects in NONMEM
Efficient Screening of Covariates in Population Models Using Wald's Approximation to the Likelihood Ratio Test
In Vivo–In Vitro Correlation (IVIVC) Modeling Incorporating a Convolution Step
Population Pharmacokinetic Analysis and Optimization of the Experimental Design for Mizolastine Solution in Children